☰

Lucas Vitzthum - Publications

Affiliations: 
Stanford University, Palo Alto, CA 
Area:
Oligometastatic cancer, health services research, data science
Tree Info Similar researchers PubMed Report error

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Liu HC, Williamson CW, Zou J, Todd JR, Nelson TJ, Hill LM, Linnemeyer KE, Henderson G, Madgula P, Faung B, Sacco AG, Vitzthum LK, Weissbrod PA, Blumenfeld LS, Mell LK. Quantitative prediction of aspiration risk in head and neck cancer patients treated with radiation therapy. Oral Oncology. 136: 106247. PMID 36410204 DOI: 10.1016/j.oraloncology.2022.106247  0.62
2022 Hui C, Baclay R, Liu K, Sandhu N, Loo P, von Eyben R, Chen C, Sheth V, Vitzthum L, Chang D, Pollom E. Rectosigmoid Cancer-Rectal Cancer or Sigmoid Cancer? American Journal of Clinical Oncology. PMID 35848736 DOI: 10.1097/COC.0000000000000931  0.37
2022 Qiao EM, Qian AS, Nalawade V, Voora RS, Kotha NV, Vitzthum LK, Murphy JD. Evaluating High-Dimensional Machine Learning Models to Predict Hospital Mortality Among Older Patients With Cancer. Jco Clinical Cancer Informatics. 6: e2100186. PMID 35671416 DOI: 10.1200/CCI.21.00186  0.453
2022 Nelson TJ, Thompson CA, Zou J, Kumar A, Sangchan P, Williamson CW, Vitzthum LK, Sharabi AB, Murphy JD, Fakhry CA, Mell LK. Validation of NRG Oncology's prognostic nomograms for oropharyngeal cancer in the Veterans Affairs database. Cancer. PMID 35194791 DOI: 10.1002/cncr.34141  0.599
2022 Williamson CW, Nelson T, Thompson CA, Vitzthum LK, Zakeri K, Riviere P, Bryant AK, Sharabi AB, Zou J, Mell LK. Bias Reduction through Analysis of Competing Events (BRACE) Correction to Address Cancer Treatment Selection Bias in Observational Data. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35140122 DOI: 10.1158/1078-0432.CCR-21-2468  0.552
2022 Vitzthum LK, Nalawade V, Riviere P, Marar M, Furnish T, Lin LA, Thompson R, Murphy JD. Impacts of an Opioid Safety Initiative on United States Veterans Undergoing Cancer Treatment. Journal of the National Cancer Institute. PMID 35078240 DOI: 10.1093/jnci/djac017  0.477
2022 Salans M, Riviere P, Vitzthum LK, Nalawade V, Murphy JD. Temporal Trends and Predictors of Opioid Use Among Older Patients With Cancer. American Journal of Clinical Oncology. PMID 35019879 DOI: 10.1097/COC.0000000000000888  0.524
2021 Qiao EM, Voora RS, Nalawade V, Kotha NV, Qian AS, Nelson TJ, Durkin M, Vitzthum LK, Murphy JD, Stewart TF, Rose BS. Evaluating the clinical trends and benefits of low-dose computed tomography in lung cancer patients. Cancer Medicine. PMID 34528761 DOI: 10.1002/cam4.4229  0.457
2021 Sumner W, Kim SS, Vitzthum L, Moore K, Atwood T, Murphy J, Miyauchi S, Califano JA, Mell LK, Mundt AJ, Sharabi AB. End of treatment cone-beam computed tomography (CBCT) is predictive of radiation response and overall survival in oropharyngeal squamous cell carcinoma. Radiation Oncology (London, England). 16: 147. PMID 34372887 DOI: 10.1186/s13014-021-01871-w  0.557
2021 Vitzthum LK, Nalawade V, Riviere P, Sumner W, Nelson T, Mell LK, Furnish T, Rose B, Martínez ME, Murphy JD. Racial, Ethnic, and Socioeconomic Discrepancies in Opioid Prescriptions Among Older Patients With Cancer. Jco Oncology Practice. OP2000773. PMID 33534647 DOI: 10.1200/OP.20.00773  0.625
2020 Riviere P, Vitzthum LK, Nalawade V, Deka R, Furnish T, Mell LK, Rose BS, Wallace M, Murphy JD. Validation of an oncology-specific opioid risk calculator in cancer survivors. Cancer. PMID 33378556 DOI: 10.1002/cncr.33410  0.661
2020 Zakeri K, Rotolo F, Lacas B, Vitzthum LK, Le QT, Gregoire V, Overgaard J, Hackshaw A, Zackrisson B, Parmar MKB, Burtness BA, Ghi MG, Sanguineti G, O'Sullivan B, Fortpied C, et al. Predictive classifier for intensive treatment of head and neck cancer. Cancer. PMID 33017867 DOI: 10.1002/cncr.33212  0.609
2020 Kumar A, Straka C, Courtney PT, Vitzthum L, Riviere P, Murphy JD. Cost-effectiveness Analysis of Stereotactic Ablative Radiotherapy in Patients with Oligometastatic Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 33002541 DOI: 10.1200/Jco.2020.38.15_Suppl.7085  0.55
2020 Vitzthum LK, Heide ES, Park H, Williamson CW, Sheridan P, Huynh-Le MP, Sirak I, Wei L, Tarnawski R, Mahantshetty U, Nguyen C, Mayadev J, Yashar CM, Sacco AG, Mell LK. Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing Chemoradiotherapy. Frontiers in Oncology. 10: 1179. PMID 32793487 DOI: 10.3389/fonc.2020.01179  0.533
2020 Vitzthum LK, Riviere P, Murphy JD. Managing Cancer Pain During the Opioid Epidemic-Balancing Caution and Compassion. Jama Oncology. PMID 32379274 DOI: 10.1001/Jamaoncol.2020.0779  0.459
2020 Deka R, Parsons JK, Simpson DR, Riviere P, Nalawade V, Vitzthum LK, Kader AK, Kane CJ, Rock CS, Murphy JD, Rose BS. African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance. Prostate Cancer and Prostatic Diseases. PMID 32327702 DOI: 10.1038/S41391-020-0230-6  0.461
2020 Simon AB, Vitzthum LK, Mell LK. Challenge of Directly Comparing Imaging-Based Diagnoses Made by Machine Learning Algorithms With Those Made by Human Clinicians. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1903350. PMID 32271670 DOI: 10.1200/Jco.19.03350  0.371
2020 Kumar A, Riviere P, Luterstein E, Nalawade V, Vitzthum L, Sarkar RR, Bryant AK, Einck JP, Mundt AJ, Murphy JD, Rose BS. Associations among statins, preventive care, and prostate cancer mortality. Prostate Cancer and Prostatic Diseases. PMID 32029930 DOI: 10.1038/S41391-020-0207-5  0.523
2020 Riviere P, Luterstein E, Kumar A, Vitzthum LK, Deka R, Sarkar RR, Bryant AK, Bruggeman A, Einck JP, Murphy JD, Martinez E, Rose BS. Survival of African American and non-Hispanic white men with prostate cancer in an equal-access health care system. Cancer. PMID 31984482 DOI: 10.1002/Cncr.32666  0.431
2020 Salans MA, Riviere P, Vitzthum L, Nalawade V, Murphy JD. Trends in short-term, long-term, and high-risk opioid use among older cancer patients. Journal of Clinical Oncology. 38: 187-187. DOI: 10.1200/jco.2020.38.29_suppl.187  0.487
2020 Williamson C, Vitzthum L, Zou J, Zakeri K, Sharabi A, Murphy J, Mell L. Competing Risk Analysis to Address Selection Bias in Comparative Effectiveness Research International Journal of Radiation Oncology*Biology*Physics. 108: S145-S146. DOI: 10.1016/j.ijrobp.2020.07.890  0.413
2020 Vitzthum L, Riviere P, Nelson T, Mell L, Rose B, Murphy J. Rates of New Opioid Prescription during Curative Intent Cancer Treatment by Race and Socioeconomic Status International Journal of Radiation Oncology*Biology*Physics. 108: S98-S99. DOI: 10.1016/j.ijrobp.2020.07.2272  0.536
2019 Vitzthum LK, Straka C, Sarkar RR, McKay R, Randall JM, Sandhu A, Murphy JD, Rose BS. Combined Androgen Blockade in Localized Prostate Cancer Treated With Definitive Radiation Therapy. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 1497-1504. PMID 31805534 DOI: 10.6004/Jnccn.2019.7335  0.49
2019 Vitzthum LK, Riviere P, Sheridan P, Nalawade V, Deka R, Furnish T, Mell LK, Rose B, Wallace M, Murphy JD. Predicting Persistent Opioid Use, Abuse and Toxicity Among Cancer Survivors. Journal of the National Cancer Institute. PMID 31754696 DOI: 10.1093/Jnci/Djz200  0.614
2019 Riviere P, Kumar A, Luterstein E, Vitzthum LK, Nalawade V, Sarkar RR, Bryant AK, Einck JP, Mundt AJ, Murphy JD, Rose BS. Tobacco smoking and death from prostate cancer in US veterans. Prostate Cancer and Prostatic Diseases. PMID 31624316 DOI: 10.1038/S41391-019-0178-6  0.468
2019 Vitzthum LK, Park H, Zakeri K, Heide ES, Nalawade V, Mundt AJ, Vaida F, Murphy JD, Mell LK. Risk of Pelvic Fracture with Radiation Therapy in Older Patients. International Journal of Radiation Oncology, Biology, Physics. PMID 31610251 DOI: 10.1016/J.Ijrobp.2019.10.006  0.574
2019 Vitzthum LK, Park H, Zakeri K, Bryant AK, Feng C, Shen H, Cohen EEW, Murphy JD, Mell LK. Selection of Head and Neck Cancer Patients for Intensive Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 31580929 DOI: 10.1016/J.Ijrobp.2019.09.011  0.668
2019 Mell LK, Shen H, Nguyen-Tan PF, Rosenthal DI, Zakeri K, Vitzthum LK, Frank SJ, Schiff PB, Trotti A, Bonner JA, Jones CU, Yom SS, Thorstad WL, Wong S, Shenouda G, et al. Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31420360 DOI: 10.1158/1078-0432.Ccr-19-1832  0.632
2019 Vitzthum L, Riviere P, Sheridan P, Nalawade V, Deka R, Xu R, Mell LK, Wallace M, Murphy JD. Predicting Persistent Opioid Use, Abuse and Toxicity Among Cancer Survivors International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.524  0.644
2019 Vitzthum L, Park H, Zakeri K, Sojourner E, Nalawade V, Mundt A, Murphy J, Mell L. Risk of Pelvic Fracture by Type of Radiation Therapy in Older Patients International Journal of Radiation Oncology*Biology*Physics. 105: S217. DOI: 10.1016/J.Ijrobp.2019.06.299  0.599
2019 Riviere P, Vitzthum L, Nalawade V, Rose BS, Murphy JD. Characterization and Prediction of Opioid Use in Head and Neck Cancer Patients Undergoing Local Therapy International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.293  0.609
2019 Riviere P, Luterstein E, Kumar A, Vitzthum L, Sarkar RR, Bryant AK, Bruggeman A, Martinez E, Murphy JD, Rose BS. Racial Equity among African-American and Non-Hispanic White Men Diagnosed with Prostate Cancer in the Veterans Affairs Healthcare System International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1864  0.502
2019 Vitzthum L, Straka CA, Sarkar RR, Mckay R, Murphy JD, Rose BS. Combined Androgen Blockade in Men with Intermediate and High Risk Localized Prostate Cancer Treated with Definitive Radiation Therapy International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1781  0.554
2019 Straka CA, Kumar A, Riviere P, Azuara A, Vitzthum L, Murphy JD. eHealth Survey of Spanish Speaking Patients and Caregivers International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1467  0.427
2019 Riviere P, Kumar A, Vitzthum L, Luterstein E, Sarkar RR, Bryant AK, Einck JP, Mundt AJ, Murphy JD, Rose BS. Association between Tobacco Smoking and Prostate Cancer-Specific Mortality in the Veterans Affairs Healthcare System International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1433  0.494
2018 Vitzthum LK, Feng CH, Noticewala S, Hines PJ, Nguyen C, Zakeri K, Sojourner EJ, Shen H, Mell LK. Comparison of Comorbidity and Frailty Indices in Patients With Head and Neck Cancer Using an Online Tool. Jco Clinical Cancer Informatics. 1-9. PMID 30652602 DOI: 10.1200/CCI.18.00082  0.575
2018 Zakeri K, Panjwani N, Carmona R, Shen H, Vitzthum LK, Zhang QE, Murphy JD, Mell LK. Generalized Competing Event Models Can Reduce Cost and Duration of Cancer Clinical Trials. Jco Clinical Cancer Informatics. 1-12. PMID 30652559 DOI: 10.1200/CCI.17.00124  0.601
2018 Zakeri K, Noticewala SS, Vitzthum LK, Sojourner E, Shen H, Mell LK. 'Optimism bias' in contemporary national clinical trial network phase III trials: are we improving? Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: 2135-2139. PMID 30412223 DOI: 10.1093/Annonc/Mdy340  0.474
2018 Vitzthum LK, Mell LK. The role of p16 as a biomarker in nonoropharyngeal head and neck cancer. Oncotarget. 9: 33247-33248. PMID 30279955 DOI: 10.18632/oncotarget.26053  0.544
2018 Bryant AK, Sojourner EJ, Vitzthum LK, Zakeri K, Shen H, Nguyen C, Murphy JD, Califano JA, Cohen EEW, Mell LK. Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer. Journal of the National Cancer Institute. PMID 29878161 DOI: 10.1016/J.Ijrobp.2017.12.037  0.614
2018 Feng C, Vitzthum L, Sojourner E, Zakeri K, Nguyen C, Straka C, Mell L. Assessment of Interrater Reliability for Comorbidity Indices in Determining Eligibility for Treatment Intensification in Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e197-e198. DOI: 10.1016/J.Ijrobp.2018.07.707  0.595
2018 Sojourner E, Park H, Feng C, Vitzthum L, Sirak I, Wei L, Tarnawski R, Mahantshetty U, Mell L. Variation in Hematologic Toxicity in Patients Undergoing Radiation Therapy with Concurrent Weekly Cisplatin for Head and Neck Versus Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e636. DOI: 10.1016/J.Ijrobp.2018.07.1735  0.62
2018 Vitzthum L, Feng C, Zakeri K, Sojourner E, Murphy J, Mell L. Patterns of Care Among Elderly US Veterans Treated for Head and Neck Cancer with Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 102: e359-e360. DOI: 10.1016/J.Ijrobp.2018.07.1083  0.656
2017 Vitzthum L, Noticewala S, Hines P, Zakeri K, Nguyen C, Shen H, Mell L. A Web-Based Tool to Compare Comorbidity Models and Geriatric Risk-Assessment in Head and Neck Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 99: E379. DOI: 10.1016/J.Ijrobp.2017.06.1508  0.613
2014 Vitzthum L, Jones D, Boldt A, Dusenbery K. Identifying and Implementing Factors That Will Reduce Treatment Package Time for Cervical Cancer Patients Requiring Definitive Radiation Therapy: A Quality Improvement Effort International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.2145  0.423
Show low-probability matches.